Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.94 USD | -0.73% | +0.31% | -9.73% |
06-18 | Stifel Initiates Celldex Therapeutics at Buy Rating With $58 Price Target | MT |
06-11 | Celldex Therapeutics Insider Sold Shares Worth $1,586,844, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.73% | 2.39B | |
+26.71% | 52.73B | |
+37.49% | 39B | |
-9.22% | 38.52B | |
+29.41% | 30.38B | |
-12.26% | 26.39B | |
+10.72% | 26.08B | |
+45.24% | 14.15B | |
+32.44% | 12.6B | |
-5.98% | 11.51B |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $156,000